Home›Stocks›RCEL

RCEL — structural market context

Avita Medical, Inc. Common Sto

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

RCEL short interest & days to cover

SHARES SHORT
2.9M
% OF FLOAT
—
DAYS TO COVER
6.9
CHANGE VS PRIOR
+6.9%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-08-31 (12d ago)

RCEL fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-08-14 · 29d7K$8.01
2026-08-12 · 31d4K$8.2
2026-08-11 · 32d13K$7.6

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

RCEL insider buying and selling (Form 4)

Last 12 months, open-market only: 1 purchase · 0 sales

InsiderTypeSharesValueFiled
O'Toole David D · officer: CFOBuy (P)2K$8K2026-08-24

SEC Form 4 filings, open-market purchases and sales only (codes P and S); grants and option exercises excluded. Attributed public records.

RCEL analyst ratings — with each firm's measured accuracy

FirmActionRatingFirm 5d hit rate*Published
Lake StreetholdBuyn<302026-08-28
Lake Streetprice_target—n<302026-08-28
Cowen & Co.holdBuyn<302026-08-19
BTIGholdBuyn<302026-08-19
BTIGprice_target—n<302026-08-19

*Rating actions from public feeds. Where shown, the firm's 5-day hit rate is our measured backtest (firms with >=30 graded calls); a historical hit rate describes past calls, it does not grade this one.

Frequently asked questions

Are insiders buying RCEL?
In the last 12 months of SEC Form 4 filings, RCEL recorded 1 open-market insider purchase and 0 open-market sales (codes P and S; grants and option exercises excluded). These are attributed public records — information, not instruction.
What do analysts say about RCEL?
The most recent action: Lake Street hold to Buy on 2026-08-28. We show each firm's measured record next to its ratings; a historical hit rate describes past calls and does not grade this one.
Is this page telling me to buy or sell RCEL?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

More tickers starting with R

RARE · Ultragenyx Pharmaceutical Inc.RCG · RENN Fund Inc.RELY · Remitly Global, Inc. Common StRGTI · Rigetti Computing, Inc. CommonRKLB · Rocket Lab Corporation CommonRMD · ResMed Inc.All R →

This is the teaser.

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.